Totus Medicines, a disruptive force in small molecule drug discovery, is set to capture the spotlight at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco. President and CEO, Nassim Usman, Ph.D., will deliver a highly anticipated corporate update on Wednesday, January 10th, 2024, at 2:30 PM PST / 5:30 PM EST.
The J.P. Morgan Healthcare Conference is the premier event for global healthcare leaders, emerging innovators, and influential investors. This year's gathering promises to be particularly noteworthy, convening under the theme "The State of Innovation in a Volatile Market."
Dr. Usman's presentation will delve into:
- Totus Medicines' groundbreaking platform that leverages DNA-encoded covalent libraries and AI/ML tools to unlock drug existing and the potential of previously "undruggable" targets.
- The company's promising pipeline of drug candidates addressing critical unmet medical needs.
To learn more about the J.P. Morgan Healthcare Conference, visit event details here.